Intravenous Autologous CD19 CAR-T Cells for R/R B-ALL
Status:
Recruiting
Trial end date:
2024-03-18
Target enrollment:
Participant gender:
Summary
This is Phase II / III, Prospective, single arm, Open Label Study to Evaluate Safety and
Efficacy of Intravenous Autologous CD19 CAR-T Cells for Relapsed / Refractory B-Acute
Lymphoblastic Leukaemia